Cano Health to Participate in the 2021 Evercore ISI Virtual HealthCONx Conference
MIAMI, Nov. 24, 2021 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO), a leading value-based primary care provider for seniors and underserved communities, today announced it will participate in the 4th Annual Evercore ISI Virtual HealthCONx Conference on Wednesday, December 1, 2021. Dr. Marlow Hernandez, Chairman and CEO, will participate in a virtual fireside chat at 8:00 a.m., Eastern Time.
A live audio webcast will be accessible through Cano Health's Investor Relations website at investors.canohealth.com. The webcast will be archived for replay following the conference.
About Cano Health
Cano Health operates value-based primary care medical centers and supports affiliated medical practices that specialize in primary care for seniors in Florida, Texas, Nevada, New York, New Jersey, New Mexico, California, Illinois, and Puerto Rico, with additional markets in development. As part of its care coordination strategy, Cano Health provides sophisticated, high-touch population health management programs including telehealth, prescription home delivery, wellness programs, transition of care, and high-risk and complex care management.
Cano Health's personalized patient care and proactive approach to wellness and preventive care sets it apart from competitors. Cano Health has consistently improved clinical outcomes while reducing costs, affording patients the opportunity to lead longer and healthier lives. Cano Health serves a predominantly minority population (80% of its patients are Latino or African American) and low-income population (50% of its members are dual eligible for Medicare and Medicaid). For more information visit www.canohealth.com or www.canohealth.com/investors/.
Media Relations Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/cano-health-to-participate-in-the-2021-evercore-isi-virtual-healthconx-conference-301431604.html
SOURCE Cano Health, Inc.
Company Codes: NYSE:CANO
© 2021 PR Newswire. All Rights Reserved.